InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Discover the full record of transactions filed by Carter Laura, Chief Scientific Officer. Officer active across 1 companies, notably Gossamer Bio, Inc.. Aggregated, 8 reports have been published. Total volume traded: €96k. The latest transaction was disclosed on 4 May 2022 — Cession. Regulator: SEC (Form 4). All data is free.
Declarations8 total
€8,5541,262 shares@ €6.77810.011% mcap8.9% of flow
Common Stock
SEC:0001728117-22-000041:0·
€37,7475,002 shares@ €7.54650.047% mcap39.1% of flow
Common Stock
SEC:0001728117-22-000027:0·
€25,0772,377 shares@ €10.5497100.0% of flow
Common Stock
SEC:0001728117-21-000098·
€25,0772,377 shares@ €10.54970.031% mcap26.0% of flow
Common Stock
SEC:0001728117-21-000098:0·
025,000 shares0
Common Stock
SEC:0001728117-21-000080·
025,000 shares0
Common Stock
SEC:0001728117-21-000080:0·
10,820 shares
Common Stock
SEC:0001728117-21-000050·
010,820 shares0
Common Stock
SEC:0001728117-21-000050:0·
8 of 8 declarations
About Carter Laura
Laura Carter is the Chief Scientific Officer at Gossamer Bio, Inc. She oversees research and development initiatives aimed at innovating in the biotechnology field. Carter is recognized for her scientific expertise and commitment to advancing medical treatments.
